Chemed Corp. reported a 1.6% revenue increase to $657.5 million in Q1 2026, driven by strong performance at its VITAS healthcare segment, which saw a 3.1% rise in net patient revenue and a 6.9% increase in admissions. Despite a slight decline in Roto-Rooter revenues, Chemed repurchased 500,000 shares and acquired two franchises for $20.6 million. The company raised its full-year guidance for 2026, expecting higher average daily census growth and improved EBITDA margins at VITAS, while maintaining steady revenue growth expectations for Roto-Rooter. Chemed also secured a new $450 million credit agreement to support operations and growth.
Lockheed Martin Ventures, the $1 billion venture capital arm of Lockheed Martin, is expanding into the UK and Europe with a new London office. It plans to invest at least $100 million in defense technology startups to strengthen transatlantic defense...
Ether has surged about 11% over the past week, outperforming other major cryptocurrencies like Bitcoin, which rose 4%. This rise is driven by $96 million inflows into U.S. spot ether ETFs, mainly BlackRock’s low-fee funds, while Grayscale’s higher-fe...
Veea Inc. has announced the commercial release of VeeaONE, a full-stack AI infrastructure platform that integrates edge-to-cloud hardware and software. The platform supports VeeaWare middleware on NVIDIA Jetson and x86/Arm servers, enabling secure, l...
Virtuals Protocol has introduced customizable tokenized indexes on the Robinhood Chain, allowing users to combine multiple assets into a single token. This innovation enables users to create and manage their own asset baskets and earn fees when other...
US spot Bitcoin ETFs saw net inflows of $107.8 million on Wednesday, while Ethereum ETFs attracted $53.8 million, signaling renewed institutional interest in crypto funds. Since their launch in January 2024, Bitcoin ETFs have accumulated over $51 bil...
